In dueling perspectives, experts make their case for and against going with PCI before even trying antianginal medications.
When surveyed, many physicians said the belief that patients had adequate symptom control was why they didn’t add more meds.
Though a causative link remains speculative, interventions that foster well-being may be a way to make inroads into residual ...
Asian Indian and Filipino populations seemed to need the most improvement with regard to treatment time and medical therapy.
The results may help organizations individualize interventions to prevent burnout and foster a culture where people feel ...
September 17, 2024 | Dr. Ami Bhatt interviews Dr. Patho Sengupta.
While awaiting more definitive RCTs, it would be reasonable to exclude the LAA in some of these patients, one expert says.
September 17, 2024 | Dr. Ami Bhatt interviews Dr. Patricia Bandettini.
Of note, the update is endorsed by EACTS, resolving some lingering left main debate, amid lots of other revised advice.
Benoy Shah and Kathryn Berlacher discuss the shifting roles of physicians and other healthcare supports in the UK and the US, and the impact on scope and training.
Growing interest in the technology plus a novel tracer on the way may induce change in coming years, says Marcelo Di Carli.
The majority of FDA-recalled devices made it to market via the 510(k) pathway, which doesn’t require new clinical or safety ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results